- Home
- A-Z Publications
- Current Pharmaceutical Design
- Previous Issues
- Volume 8, Issue 23, 2002
Current Pharmaceutical Design - Volume 8, Issue 23, 2002
Volume 8, Issue 23, 2002
-
-
Amylin and Adrenomedullin: Novel Regulators of Bone Growth
Authors: J. Cornish and D. NaotBone growth is regulated by circulating hormones and locally generated factors. Understanding their mechanisms of action enables us to obtain a better appreciation of the cellular and molecular basis of bone remodelling, and could therefore be valuable in approaches to new therapies. In this review, we consider the actions on bone tissue of the peptide hormones amylin and adrenomedullin, known to circulate at picomolar co Read More
-
-
-
The Importance of Growth Hormone (GH) and GH Secretagogues for Bone Mass and Density
By J. SvenssonPotent antiresorptive agents have been developed for the treatment of osteoporosis and bone disorders. There are few agents available that stimulate bone formation. Recently, treatment with parathyroid hormone was found to induce a potent increase in hip and lumbar bone mineral density (BMD). The present review focus on growth hormone (GH) / growth hormone secretagogues (GHSs). GH / GHSs stimulates bone t Read More
-
-
-
Selective Inhibition of Osteoclast Vacuolar H+-ATPase
Authors: C. Farina and S. GagliardiThe proton pump expressed on the plasma membrane of bone resorbing osteoclasts, and which mediates the acidification of the extracellular environment in resorption lacuna, belongs to the family of vacuolar H+-ATPases, which are enzymes ubiquitously distributed among all cells and are evolutionary conserved. These pumps have two functional domains: a peripherally associated cytoplasmatic section, and a proton c Read More
-
-
-
Targeting Protein Kinases for Bone Disease: Discovery and Development of Src Inhibitors
Authors: C.A. Metcalf III, M. van Schravendijk, D.C. Dalgarno and T.K. SawyerThe dynamic and highly regulated processes of bone remodeling involve two major cells, osteoclasts and osteoblasts, both of which command a multitude of cellular signaling pathways involving protein kinases. Of the possible kinases in these cells, Src tyrosine kinase stands out as a promising therapeutic target for bone disease as validated by Src knockout mouse studies and in vitro cellular experiments, suggesting Read More
-
-
-
Pharmacological Regulation of Parathyroid Hormone Secretion
By E.F. NemethParathyroid hormone (PTH) is the key endocrine factor regulating systemic Ca2+ homeostasis. Elevated levels of circulating PTH increase bone turnover and, depending on the duration of elevation, will result in net anabolic or catabolic effects on the skeleton. Secretion of PTH from the parathyroid glands is regulated by small changes in circulating levels of Ca2+ which are detected by a Ca2+ receptor on the surface of Read More
-
-
-
SERMs: Evolutionary Chemistry, Revolutionary Biology
By C.P. MillerEstrogens are known as important modulators of development, growth and maintenance of primary sexual physiology. The medical field has also grown increasingly appreciative of the effects of estrogens on non-traditional target tissues such as bone, cardiovascular tissue and the CNS. Postmenopausal women have been the beneficiaries of estrogen supplementation regimes, but the proliferative actions of estrogens on Read More
-
Volumes & issues
-
Volume 31 (2025)
-
Volume 30 (2024)
-
Volume 29 (2023)
-
Volume 28 (2022)
-
Volume 27 (2021)
-
Volume 26 (2020)
-
Volume 25 (2019)
-
Volume 24 (2018)
-
Volume 23 (2017)
-
Volume 22 (2016)
-
Volume 21 (2015)
-
Volume 20 (2014)
-
Volume 19 (2013)
-
Volume 18 (2012)
-
Volume 17 (2011)
-
Volume 16 (2010)
-
Volume 15 (2009)
-
Volume 14 (2008)
-
Volume 13 (2007)
-
Volume 12 (2006)
-
Volume 11 (2005)
-
Volume 10 (2004)
-
Volume 9 (2003)
-
Volume 8 (2002)
-
Volume 7 (2001)
-
Volume 6 (2000)
Most Read This Month
Article
content/journals/cpd
Journal
10
5
false
en
